A Phase III Trial For Patients With Metastatic Breast Cancer

Clinical trial NCT00191152 · COMPLETED

Trial details

NCT number: NCT00191152
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms Cancer of the Breast

Start date: 2002-02-01
Primary completion: 2008-11-01
Enrollment: 475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.